Not applicableUnknownNCT01327807What this trial is testingCure Cystinosis International RegistryWho this might be right forCystinosisNephropathic CystinosisRenal Fanconi Syndrome Cystinosis Research Foundation 750
Not applicableStudy completedNCT05307926What this trial is testingPostoperative Adjuvant Therapy of HCC Based on PD-1Who this might be right forHepatocellular CarcinomaRFS Chen Xiaoping 573
Not applicableWithdrawnNCT02837523What this trial is testingBiomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)Who this might be right forRenal Fanconi SyndromePhotophobiaHypophosphatemia CENTOGENE GmbH Rostock
Large-scale testing (Phase 3)Looking for participantsNCT06644937What this trial is testingSingle-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of RecurrenceWho this might be right forHepatocellular Carcinoma (HCC) Zhujiang Hospital 30
Large-scale testing (Phase 3)UnknownNCT00005869What this trial is testingNitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00005826What this trial is testingNitrocamptothecin in Treating Patients With Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 17
Not applicableLooking for participantsNCT06065852What this trial is testingNational Registry of Rare Kidney DiseasesWho this might be right forAdenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more UK Kidney Association 35,000
Not applicableStudy completedNCT02829086What this trial is testingEvaluation of the Refugee Family Strengthening (RFS) ProgramWho this might be right forHealth Behavior US Committee for Refugees and Immigrants 5,365
Testing effectiveness (Phase 2)Study completedNCT00005875What this trial is testingNitrocamptothecin in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00006026What this trial is testingNitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 21
Testing effectiveness (Phase 2)Study completedNCT00005874What this trial is testingNitrocamptothecin in Treating Patients With Soft Tissue SarcomasWho this might be right forGastrointestinal Stromal TumorSarcomaSmall Intestine Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06910813What this trial is testingDFT383 in Pediatric Participants With Nephropathic CystinosisWho this might be right forNephropathic Cystinosis Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00006230What this trial is testingNitrocamptothecin in Treating Patients With Advanced Ovarian CancerWho this might be right forOvarian Cancer European Organisation for Research and Treatment of Cancer - EORTC 51
Not applicableStudy completedNCT03886389What this trial is testingBreast Cancer Diet Intervention StudyWho this might be right forEarly-stage Breast CancerCarbohydrate EngorgementProliferation+2 more Helse Stavanger HF 80
Not applicableLooking for participantsNCT06287541What this trial is testingThe Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral ResectionWho this might be right forNon Muscle Invasive Bladder Cancer The First Affiliated Hospital with Nanjing Medical University 428
Large-scale testing (Phase 3)UnknownNCT00005871What this trial is testingNitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic CancerWho this might be right forPancreatic Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT00005876What this trial is testingNitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryWho this might be right forEsophageal CancerGastric Cancer Astex Pharmaceuticals, Inc.
Large-scale testing (Phase 3)UnknownNCT00005870What this trial is testingNitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the PancreasWho this might be right forPancreatic Cancer Astex Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00113256What this trial is testingOrathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Astex Pharmaceuticals, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00005873What this trial is testingNitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Astex Pharmaceuticals, Inc.